Tag: <span>cancer risk</span>

Home / cancer risk
Post

J&J recalls Neutrogena, Aveeno spray sunscreens over possible cancer risk

Johnson & Johnson on Wednesday issued a voluntary recall of five Neutrogena and Aveeno spray sunscreens after internal testing identified potential cancer-causing chemicals in some samples. Driving the news: J&J said consumers should stop using and dispose of the products. The company is notifying distributors and retailers to stop sales and arrange for returns. Details: J&J said it doesn’t...

Post

Cancer risk in ART children and young adults is not increased

EUROPEAN SOCIETY OF HUMAN REPRODUCTION AND EMBRYOLOGY 28 June 2021: The risk of cancer in children born as a result of fertility treatment has been found to be no greater than in the general population.  Results presented today at the 37th Annual Meeting of ESHRE from an 18-year median follow-up study demonstrate that the overall...

Research offers insights on how night shift work increases cancer risk
Post

Research offers insights on how night shift work increases cancer risk

WASHINGTON STATE UNIVERSITY IMAGE: A NIGHT SHIFT SCHEDULE IS ASSOCIATED WITH INCREASED DNA DAMAGE AND MISALIGNMENT OF THE DNA REPAIR MECHANISM, PROVIDING A POSSIBLE EXPLANATION FOR THE ELEVATED RISK OF CANCER IN NIGHT SHIFT WORKERS. CREDIT: BALA KORITALA SPOKANE, Wash. – New clues as to why night shift workers are at increased risk of developing...

Post

Does aspirin lower colorectal cancer risk in older adults? It depends on when they start.

MASSACHUSETTS GENERAL HOSPITAL BOSTON – Regular aspirin use has clear benefits in reducing colorectal cancer incidence among middle-aged adults, but also comes with some risk, such as gastrointestinal bleeding. And when should adults start taking regular aspirin and for how long? There is substantial evidence that a daily aspirin can reduce risk of colorectal cancer...

FDA requests market withdrawal of diet drug Belviq due to cancer risk
Post

FDA requests market withdrawal of diet drug Belviq due to cancer risk

A clinical trial of the weight-loss drug Belviq (lorcaserin) shows an association with an increased risk of cancer, and the U.S. Food and Drug Administration is requesting that its maker withdraw the drug from the U.S. market. Eisai Inc. has already “submitted a request to voluntarily withdraw the drug,” Dr. Janet Woodcock, who directs the...

Post

FDA: Weight-control drug lorcaserin may raise cancer risk

The prescription weight control medicine lorcaserin (Belviq, Belviq XR) may increase the risk for cancer, according to the results of a clinical trial assessing the safety of the drug, the U.S. Food and Drug Administration says. The agency said, “[W]e cannot conclude that lorcaserin contributes to the cancer risk” but “wanted to make the public...

Post

Permanent hair dye and straighteners may increase breast cancer risk

NIH/NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES Scientists at the National Institutes of Health found that women who use permanent hair dye and chemical hair straighteners have a higher risk of developing breast cancer than women who don’t use these products. The study published online Dec. 4 in the International Journal of Cancer and suggests that...

Post

Overweight before age 40 increases cancer risk

by Kim E. Andreassen, University of Bergen In an international study, lead by the University of Bergen, the researchers wanted to find out how adult overweight (BMI over 25) and obesity (BMI over 30) increase the risk of different types of cancer. The study showed that if you were overweight before age 40, the risk of developing cancer increases by:  70 percent for endometrial cancer.  58 percent for male renal-cell cancer. 29...

Post

Can you ‘catch’ cancer?

Parasitic worms cause cancer — and could help cure it FRONTIERS Billions worldwide are infected with tropical worms. Unsurprisingly, most of these people live in poor countries, kept poor by the effects of worm-related malnourishment. What may surprise many is that worms also cause the majority of cancer cases in these countries. Published in Frontiers in Medicine as a special article...